e-learning
resources
Milan 2017
Tuesday, 12.09.2017
Insight into the pathogenesis of emphysema and pneumonia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Host extracellular nucleic acids in severe pneumococcal pneumonia: Pathogenic mechanisms and therapeutic approaches
L. Teixeira Alves (Berlin, Germany)
Source:
International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia
Session:
Insight into the pathogenesis of emphysema and pneumonia
Session type:
Thematic Poster
Number:
3935
Disease area:
Respiratory critical care, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Teixeira Alves (Berlin, Germany). Host extracellular nucleic acids in severe pneumococcal pneumonia: Pathogenic mechanisms and therapeutic approaches. 3935
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Identification of extracellular nucleic acids and neutrophil extracellular traps in blood of patients with community-acquired pneumonia
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015
Differentiation between pneumococcal and viral pneumonia in children: what is the best combination of nonspecific markers?
Source: Eur Respir J 2001; 18: Suppl. 33, 180s
Year: 2001
Cationic host defence peptides as a novel treatment for respiratory viral infections
Source: International Congress 2018 – Antimicrobial host defence and innate immunity in the lung
Year: 2018
Interactions between bacterial and viral infections during COPD exacerbations: implications for prevention strategies
Source: International Congress 2019 – Scientific Year in review
Year: 2019
Risk factors for respiratory failure in pneumococcal pneumonia: the importance of pneumococcal serotypes
Source: Eur Respir J 2014; 43: 545-553
Year: 2013
Dynamics of IFN-ß responses during respiratory viral infection: insights for therapeutic strategies
Source: International Congress 2019 – Mechanisms underlying respiratory infection
Year: 2019
The pathophysiology of pneumococcal pneumonia
Source: Eur Respir Monogr 2014; 63: 42-63
Year: 2014
Molecular analysis with nucleic acid-based assays increase pathogen detection of pleural empyema
Source: International Congress 2015 – Challenges in surgery for non-malignant disorders: pleural mediastinal and tracheal problems, congenital disorders
Year: 2015
Influence of the infecting serotype on the development of complications in bacteriemic pneumococcal pneumonia with high inflammatory response
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020
Challenges in understanding host genetics and severity of community-acquired pneumonia
Source: ERJ Open Res, 7 (1) 00745-2020; 10.1183/23120541.00745-2020
Year: 2021
Late Breaking Abstract - Biomarkers for iron metabolism among patients hospitalized with community-acquired pneumonia caused by SARS-CoV-2, bacteria, and influenza
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021
Angiopoietins: Possible biomarkers in severe pneumonia?
Source: Annual Congress 2012 - The many roads to lung injury
Year: 2012
Potential antibiotic resistant pathogens in community-acquired pneumonia: playing it safe is anything but
Source: Eur Respir J, 54 (1) 1900870; 10.1183/13993003.00870-2019
Year: 2019
Spontaneous bacterial empyema in cirrhotic patients: pathogenic mechanisms and diagnostic tools
Source: Eur Respir J 2006; 28: Suppl. 50, 50s
Year: 2006
Biomarkers of bacterial infection
Source: Annual Congress 2008 - Is microbiological diagnosis of community-acquired pneumonia possible and useful?
Year: 2008
Resistant pathogens that cause pneumonia: a global perspective
Source: International Congress 2014 – Multidrug-resistant (MDR) pathogens that cause pneumonia
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept